Dicyclomine


w185



General information:


Withdrawn ID: w185
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): A03AA07
Molecular Formula: C19H35NO2
Molweight: 309.487



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 1950
First withdrawn: 1999
Last withdrawn: 1999
Reference: https://www.ncbi.nlm.nih.gov/pubmed/24777842



Side-effects:

Total reported cases (submitted by medical professionals) with Dicyclomine as primary suspect: 112


Reported final outcomes:
Hospitalization (initial or prolonged): 38
Life-Threatening condition: 4
Intervention required to prevent permanent impairment/damage: 3
Death: 3
Disability: 2
Congenital anomaly: 1


Reported side-effects:

Side-effect Case number
INCORRECT ROUTE OF DRUG ADMINISTRATION25
MEDICATION ERROR14
DRUG INEFFECTIVE11
Pancreatitis acute10
Drug hypersensitivity9
DIZZINESS9
VISION BLURRED8
Off label use8
NAUSEA8
Hypersensitivity8
CONFUSIONAL STATE8
Hyperhidrosis7
HEADACHE7
AGITATION7
VOMITING6
TOXICITY TO VARIOUS AGENTS6
Mydriasis6
HALLUCINATION6
DISORIENTATION6
DELIRIUM6
CONSTIPATION6
ANXIETY6
DYSARTHRIA5
Completed suicide5
Abdominal pain5
URINARY TRACT INFECTION4
TREMOR4
THROMBOSIS4
RHABDOMYOLYSIS4
RASH4
PALPITATIONS4
OVERDOSE4
Neuroleptic malignant syndrome4
NERVOUSNESS4
Hypothermia4
FATIGUE4
Drug dependence4
Drug abuse4
DEPRESSION4
Acute kidney injury4
ABDOMINAL DISCOMFORT4
Wrong product administered3
WEIGHT DECREASED3
Tachycardia3
SYNCOPE3
PAIN IN EXTREMITY3
MUSCULAR WEAKNESS3
Metabolic acidosis3
Intentional overdose3
INSOMNIA3
DYSPNOEA3
DRY MOUTH3
Drug interaction3
DIARRHOEA3
DEHYDRATION3
DECREASED APPETITE3
CONDITION AGGRAVATED3
Asthenia3
AMNESIA3
Alkalosis hypochloraemic3
VISUAL IMPAIRMENT2
Urticaria2
THROMBOPHLEBITIS2
Stereotypy2
SOMNOLENCE2
Shock2
Septic shock2
PYREXIA2
Product packaging confusion2
Product name confusion2
Product label confusion2
PHLEBITIS2
PAIN2
MUSCLE SPASMS2
MIGRAINE2
MENTAL STATUS CHANGES2
MENTAL IMPAIRMENT2
Incorrect route of product administration2
HYPOAESTHESIA2
HEART RATE DECREASED2
Gait disturbance2
FOOD INTOLERANCE2
Food allergy2
FEELING ABNORMAL2
Euphoric mood2
Embolia cutis medicamentosa2
DRY SKIN2
Dry eye2
Drug withdrawal syndrome2
Depressed level of consciousness2
CHEST PAIN2
BLOOD PRESSURE INCREASED2
Ataxia2
ANAPHYLACTIC REACTION2
Abdominal pain upper2
WRONG DRUG ADMINISTERED1
Withdrawal syndrome1
Withdrawal hypertension1
Wheezing1
Weight bearing difficulty1
VEIN DISORDER1
Urinary retention1
Urinary incontinence1
URINARY HESITATION1
Transcription medication error1
Tobacco interaction1
Tic1
Therapeutic response unexpected1
Therapeutic response decreased1
Swelling face1
SPEECH DISORDER1
SKULL MALFORMATION1
SKIN WRINKLING1
SKIN TIGHTNESS1
Sinus tachycardia1
RHEUMATOID ARTHRITIS1
RETINAL OEDEMA1
Retching1
Restlessness1
RENAL FAILURE ACUTE1
RENAL FAILURE1
RECTOURETHRAL FISTULA1
PSYCHOTIC DISORDER1
PSEUDODEMENTIA1
Pruritus1
Product use in unapproved indication1
Product substitution issue1
Product selection error1
Product preparation error1
Product dispensing error1
Product design confusion1
Product confusion1
Product appearance confusion1
POSTOPERATIVE INFECTION1
Photophobia1
Pharyngeal ulceration1
Pharyngeal swelling1
Peripheral coldness1
PENOSCROTAL TRANSPOSITION1
PENIS DISORDER1
PAROTITIS1
PARAESTHESIA1
Panic attack1
OSTEOARTHRITIS1
Oliguria1
Oesophagitis chemical1
OEDEMA PERIPHERAL1
OCULAR DISCOMFORT1
NEUTROPHIL MORPHOLOGY ABNORMAL1
NERVOUS SYSTEM DISORDER1
NERVE INJURY1
NEONATAL RESPIRATORY DISTRESS SYNDROME1
Neck pain1
NAEVUS FLAMMEUS1
Myalgia1
MULTIPLE CHEMICAL SENSITIVITY1
MUCOSAL DRYNESS1
Mood swings1
MONOPLEGIA1
Metastatic renal cell carcinoma1
MEMORY IMPAIRMENT1
MEGACOLON1
Maternal exposure during pregnancy1
Maternal exposure during breast feeding1
Malignant neoplasm progression1
MALABSORPTION1
Lymphadenitis1
LUPUS-LIKE SYNDROME1
LOSS OF CONSCIOUSNESS1
LIVEDO RETICULARIS1
Leukopenia1
LETHARGY1
Laboratory test abnormal1
Irritability1
INTESTINAL PERFORATION1
Intercepted product dispensing error1
Intercepted drug dispensing error1
Intentional product misuse1
Injection site paraesthesia1
INJECTION SITE PAIN1
Injection site hypoaesthesia1
INFUSION SITE PAIN1
Increased appetite1
INAPPROPRIATE AFFECT1
ILEUS1
Hypotension1
HYPOSPADIAS1
Hyporeflexia1
Hypohidrosis1
HYPOAESTHESIA ORAL1
HYPERTELORISM OF ORBIT1
Hypersomnia1
Hyperammonaemia1
HEART RATE INCREASED1
Halo vision1
HALLUCINATION, VISUAL1
Gastrointestinal pain1
GASTROINTESTINAL HAEMORRHAGE1
Gastritis1
FUMBLING1
FOETAL EXPOSURE DURING PREGNANCY1
Flushing1
Feeling of despair1
Fall1
FAECALOMA1
FAECAL INCONTINENCE1
FACIAL PAIN1
Eye swelling1
Eye inflammation1
Erythema multiforme1
Erythema1
Dysphagia1
Drug tolerance1
DRUG PRESCRIBING ERROR1
Drug monitoring procedure not performed1
DRUG LABEL CONFUSION1
Drug ineffective for unapproved indication1
Drug dispensing error1
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE1
Disinhibition1
DIET REFUSAL1
Device dislocation1
DELUSION1
CONTRAINDICATION TO MEDICAL TREATMENT1
CONGENITAL NYSTAGMUS1
Complex regional pain syndrome1
Communication disorder1
Cognitive disorder1
CLEFT LIP AND PALATE1
CHEST DISCOMFORT1
CELLULITIS1
Cardio-respiratory arrest1
BODY TEMPERATURE INCREASED1
Blood pressure decreased1
Balance disorder1
Back pain1
APPENDICITIS PERFORATED1
ANTIPSYCHOTIC DRUG LEVEL INCREASED1
ANTICHOLINERGIC SYNDROME1
ANOMALY OF ORBIT, CONGENITAL1
ANAL ATRESIA1
ALTERED STATE OF CONSCIOUSNESS1
Adverse reaction1
Administration site movement impairment1
Adjustment disorder1
ACTIVITIES OF DAILY LIVING IMPAIRED1
ACCIDENTAL OVERDOSE1
Abdominal tenderness1
Abdominal distension1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P02545 70.8 Prelamin-A/C LMNA_HUMAN
P40225 10000 Thrombopoietin TPO_HUMAN



Toxicity information:

Toxicity class: 4
Toxicity type: multiple
LD50: 600 mg/kg



External links:

ChEBML: CHEMBL1123
DrugBank: DB00804